U.S. FDA classifies Aurobindo Pharma arm Eugia’s formulation plant as OAI

As reported by thehindu.com

Aurobindo Pharma subsidiary Eugia Pharma Specialities’ formulation manufacturing facility near Hyderabad has been classified by the U.S. Food and Drug Adminis...

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on thehindu.com ↗

Market Samachar is a news aggregator. This article was originally published by thehindu.com. Tap the button above to read the full story on their site.

INDIAN What crypto investors need to know for tax season 2026 Markets-Economic Times
COMPANIES FCNR(B): Revisiting a proven crisis management tool Stocks-Markets-Economic Times
INDIAN ETMarkets Smart Talk| RBI's FPI reforms could attract $50-100 billion into Indian debt over time: Vikas Garg of Invesco MF Markets-Economic Times
INDIAN SpaceX becomes world's 7th most valuable company after blockbuster market debut Markets-Economic Times
INDIAN ET Alpha Wealth Summit | From private credit to real estate funds, alternate investments are no longer a niche play for HNIs: Lakshmi Iyer Markets-Economic Times
COMPANIES Uday Kotak questions SpaceX valuation, says only time will tell if we're in ‘mega bubble' Stocks-Markets-Economic Times
GLOBAL POET Technologies (POET) Rides Market Leaders’ Semiconductor Optimism, Climbs 11% insidermonkey.com
GLOBAL Goldman Sachs Sees Fed Delaying Rate Cuts This Year – Here’s When the Next One Is Coming dailyhodl.com

U.S. FDA classifies Aurobindo Pharma arm Eugia’s formulation plant as OAI

More from Market Samachar